Nothing can prepare you for the look of pity after you tell someone your dad died. When what used to be a funny story about ...

Scientists have uncovered a critical weakness in prostate cancer’s defences. The disease relies on two enzymes, PDIA1 and ...

“As a two-time prostate cancer survivor, I enjoy today as if it will be my last,” Jesse said. “I engage every man I meet ...

News of the study comes days after it emerged an NHS trial will use AI to interpret MRI scans from men suspected of having ...

The Vanguard Path study is led by researchers at the University of Oxford and funded with £1.9 million from the charity ...

News of the study comes days after it emerged an NHS trial will use AI to interpret MRI scans from men suspected of having ...

We transformed care for advanced prostate cancer, by validating inhibitors of androgen production as an effective cancer ...

Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute ...

Investigators analyzed exfoliated cells in urine test specimens to identify 50 candidate RNAs for prostate cancer detection.

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy.

SCREENING men for prostate cancer could slash deaths by 13 per cent, saving thousands of lives a year, a study suggests. Results of the long-term European trial – one of the largest in ...